Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2018 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
Atherosclerosis. 2018 Oct;277:477-482. doi: 10.1016/j.atherosclerosis.2018.08.011.
Atherosclerosis. 2018.
PMID: 30270088
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
Safarova MS, Ezhov MV, Afanasieva OI, Matchin YG, Atanesyan RV, Adamova IY, Utkina EA, Konovalov GA, Pokrovsky SN.
Safarova MS, et al. Among authors: utkina ea.
Atheroscler Suppl. 2013 Jan;14(1):93-9. doi: 10.1016/j.atherosclerosissup.2012.10.015.
Atheroscler Suppl. 2013.
PMID: 23357149
Clinical Trial.
Item in Clipboard
Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level.
Afanasieva O, Ezhov MV, Klesareva E, Razova O, Chubykina U, Egiazaryan M, Sherstyuk E, Afanasieva M, Utkina E, Pokrovsky S.
Afanasieva O, et al. Among authors: utkina e.
J Cardiovasc Dev Dis. 2020 Oct 15;7(4):45. doi: 10.3390/jcdd7040045.
J Cardiovasc Dev Dis. 2020.
PMID: 33076542
Free PMC article.
Item in Clipboard
Cite
Cite